{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:13:04Z","timestamp":1790521984441,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Rostock University Medical Center"},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"DFG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.canlet.2018.11.009","type":"journal-article","created":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T17:10:18Z","timestamp":1542129018000},"page":"299-309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["DNp73-induced degradation of tyrosinase links depigmentation with EMT-driven melanoma progression"],"prefix":"10.1016","volume":"442","author":[{"given":"Katharina","family":"F\u00fcrst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Steder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Logotheti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Angerilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alf","family":"Spitschak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Marquardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Engelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ottmar","family":"Herchenr\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph A.W.","family":"Rupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte M.","family":"P\u00fctzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2018.11.009_bib1","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1242\/dev.105445","article-title":"Establishing neural crest identity: a gene regulatory recipe","volume":"142","author":"Simoes-Costa","year":"2015","journal-title":"Development"},{"key":"10.1016\/j.canlet.2018.11.009_bib2","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s13238-010-0109-8","article-title":"Melanization in living organisms: a perspective of species evolution","volume":"1","author":"Vavricka","year":"2010","journal-title":"Protein Cell"},{"key":"10.1016\/j.canlet.2018.11.009_bib3","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.1073\/pnas.97.11.5889","article-title":"Endoplasmic reticulum retention is a common defect associated with tyrosinase-negative albinism","volume":"97","author":"Halaban","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.canlet.2018.11.009_bib4","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1046\/j.1523-1747.2002.01824.x","article-title":"Coexpression of wild-type tyrosinase enhances maturation of temperature-sensitive tyrosinase mutants","volume":"119","author":"Halaban","year":"2002","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.canlet.2018.11.009_bib5","doi-asserted-by":"crossref","first-page":"6210","DOI":"10.1073\/pnas.94.12.6210","article-title":"Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelanotic melanoma cells","volume":"94","author":"Halaban","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.canlet.2018.11.009_bib6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1034\/j.1600-065X.2002.18812.x","article-title":"Antigens derived from melanocyte differentiation proteins: self-tolerance, autoimmunity, and use for cancer immunotherapy","volume":"188","author":"Engelhard","year":"2002","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.canlet.2018.11.009_bib7","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1200\/JCO.2014.57.4756","article-title":"Vitiligo-like depigmentation in patients with stage III-IV melanoma receiving immunotherapy and its association with survival: a systematic review and meta-analysis","volume":"33","author":"Teulings","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2018.11.009_bib8","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0092-8674(83)90378-1","article-title":"Differentiation in mouse melanoma cells: initial reversibility and an on-off stochastic model","volume":"34","author":"Bennett","year":"1983","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2018.11.009_bib9","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1158\/0008-5472.CAN-07-2491","article-title":"In vivo switching of human melanoma cells between proliferative and invasive states","volume":"68","author":"Hoek","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2018.11.009_bib10","doi-asserted-by":"crossref","first-page":"7969","DOI":"10.1158\/0008-5472.CAN-09-0781","article-title":"Intravital imaging reveals transient changes in pigment production and Brn2 expression during metastatic melanoma dissemination","volume":"69","author":"Pinner","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2018.11.009_bib11","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3389\/fonc.2014.00367","article-title":"Effects of epithelial to mesenchymal transition on T cell targeting of melanoma cells","volume":"4","author":"Woods","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2018.11.009_bib12","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.ccr.2013.08.023","article-title":"DNp73 exerts function in metastasis initiation by disconnecting the inhibitory role of EPLIN on IGF1R-AKT\/STAT3 signaling","volume":"24","author":"Steder","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2018.11.009_bib13","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1158\/0008-5472.CAN-15-1228","article-title":"p73 and IGF1R regulate emergence of aggressive cancer stem-like features via miR-885-5p control","volume":"76","author":"Meier","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2018.11.009_bib14","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/sj.cdd.4401914","article-title":"p53\/p63\/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress","volume":"13","author":"Murray-Zmijewski","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2018.11.009_bib15","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10555-013-9424-x","article-title":"Functions, divergence and clinical value of TAp73 isoforms in cancer","volume":"32","author":"Logotheti","year":"2013","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.canlet.2018.11.009_bib16","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1038\/onc.2014.365","article-title":"A balancing act: orchestrating amino-truncated and full-length p73 variants as decisive factors in cancer progression","volume":"34","author":"Engelmann","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2018.11.009_bib17","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/ijc.11552","article-title":"Alterations of DeltaTA-p 73 splice transcripts during melanoma development and progression","volume":"108","author":"Tuve","year":"2004","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.canlet.2018.11.009_bib18","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s13402-017-0340-x","article-title":"\u0394Np73 regulates the expression of the multidrug-resistance genes ABCB1 and ABCB5 in breast cancer and melanoma cells - a short report","volume":"40","author":"Sakil","year":"2017","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.canlet.2018.11.009_bib19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1476-4598-8-61","article-title":"Antisense gapmers selectively suppress individual oncogenic p73 splice isoforms and inhibit tumor growth in vivo","volume":"8","author":"Emmrich","year":"2009","journal-title":"Mol. Canc."},{"key":"10.1016\/j.canlet.2018.11.009_bib20","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1093\/nar\/gkf424","article-title":"Selective down-regulation of tyrosinase family gene TYRP1 by inhibition of the activity of melanocyte transcription factor, MITF","volume":"30","author":"Fang","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2018.11.009_bib21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/(SICI)1096-9896(200001)190:1<39::AID-PATH492>3.0.CO;2-V","article-title":"Transcriptional activation of tyrosinase and TRP-1 by p53 links UV irradiation to the protective tanning response","volume":"190","author":"Nylander","year":"2000","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2018.11.009_bib22","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.cellbi.2006.06.009","article-title":"Increased level of p27 subunit of proteasomes and its co-localization with tyrosinase in amelanotic melanoma cells indicate its direct role in the regulation of melanin biosynthesis","volume":"30","author":"Godbole","year":"2006","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.canlet.2018.11.009_bib23","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.jid.2016.03.038","article-title":"Variation in Hsp70-1A expression contributes to skin color diversity","volume":"136","author":"Murase","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.canlet.2018.11.009_bib24","doi-asserted-by":"crossref","first-page":"13833","DOI":"10.1074\/jbc.M413087200","article-title":"Soluble tyrosinase is an endoplasmic reticulum (ER)-associated degradation substrate retained in the ER by calreticulin and BiP\/GRP78 and not calnexin","volume":"280","author":"Popescu","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2018.11.009_bib25","first-page":"1","article-title":"Response of heat shock element within the human HSP70 promoter to mutated p53 genes","volume":"6","author":"Tsutsumi-Ishii","year":"1995","journal-title":"Cell Growth Differ."},{"key":"10.1016\/j.canlet.2018.11.009_bib26","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1002\/jcp.24090","article-title":"GRP78\/BiP is a novel downstream target of IGF-1 receptor mediated signaling","volume":"227","author":"Pfaffenbach","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.canlet.2018.11.009_bib27","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/exd.12669","article-title":"The antimycotic agent clotrimazole inhibits melanogenesis by accelerating ERK and PI3K-\/Akt-mediated tyrosinase degradation","volume":"24","author":"Chung","year":"2015","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.canlet.2018.11.009_bib28","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.18632\/oncotarget.1940","article-title":"ROS-induced epithelial-mesenchymal transition in mammary epithelial cells is mediated by NF-kB-dependent activation of Snail","volume":"5","author":"Cichon","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2018.11.009_bib29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.abb.2014.04.007","article-title":"Updates of reactive oxygen species in melanoma etiology and progression","volume":"563","author":"Liu-Smith","year":"2014","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.canlet.2018.11.009_bib30","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/ng1634","article-title":"The melanocyte differentiation program predisposes to metastasis after neoplastic transformation","volume":"37","author":"Gupta","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2018.11.009_bib31","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1242\/dev.00238","article-title":"Snail precedes slug in the genetic cascade required for the specification and migration of the Xenopus neural crest","volume":"130","author":"Aybar","year":"2003","journal-title":"Development"},{"key":"10.1016\/j.canlet.2018.11.009_bib32","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1006\/dbio.2002.0605","article-title":"The IGF pathway regulates head formation by inhibiting Wnt signaling in Xenopus","volume":"244","author":"Richard-Parpaillon","year":"2002","journal-title":"Dev. Biol."},{"key":"10.1016\/j.canlet.2018.11.009_bib33","doi-asserted-by":"crossref","first-page":"6335","DOI":"10.1073\/pnas.1320577111","article-title":"MicroRNAs are critical regulators of tuberous sclerosis complex and mTORC1 activity in the size control of the Xenopus kidney","volume":"111","author":"Romaker","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.canlet.2018.11.009_bib34","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1001\/archderm.138.6.799","article-title":"Hypopigmentation associated with an adenovirus-mediated gp100\/MART-1-transduced dendritic cell vaccine for metastatic melanoma","volume":"138","author":"Tsao","year":"2002","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.canlet.2018.11.009_bib35","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2230.2008.02872.x","article-title":"Metastatic malignant melanoma associated with vitiligo-like depigmentation","volume":"34","author":"Wang","year":"2009","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.canlet.2018.11.009_bib36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5070\/D38GS7072J","article-title":"Vitiligo: a good prognostic factor in melanoma?","volume":"15","author":"Cunha","year":"2009","journal-title":"Dermatol. Online J."},{"key":"10.1016\/j.canlet.2018.11.009_bib37","doi-asserted-by":"crossref","first-page":"178","DOI":"10.5021\/ad.2009.21.2.178","article-title":"Vitiligo-like depigmentation associated with metastatic melanoma of an unknown origin","volume":"21","author":"Cho","year":"2009","journal-title":"Ann. Dermatol."},{"key":"10.1016\/j.canlet.2018.11.009_bib38","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.surg.2010.03.003","article-title":"Melanoma-assoc\u0131ated hypop\u0131gmentat\u0131on \u0131n assoc\u0131at\u0131on w\u0131th locoreg\u0131onal relapse of melanoma","volume":"150","author":"Tas","year":"2011","journal-title":"Surgery"},{"key":"10.1016\/j.canlet.2018.11.009_bib39","first-page":"E1","article-title":"Segmental vitiligo-like hypopigmentation associated with metastatic melanoma","volume":"99","author":"Cerci","year":"2017","journal-title":"Cutis"},{"key":"10.1016\/j.canlet.2018.11.009_bib40","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH729>3.0.CO;2-D","article-title":"Expression of gp100, MART-1, tyrosinase, and S100 in paraffin-embedded primary melanomas and locoregional, lymph node, and visceral metastases: implications for diagnosis and immunotherapy. A study conducted by the EORTC Melanoma Cooperative Group","volume":"193","author":"de Vries","year":"2001","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2018.11.009_bib41","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/PAS.0000000000000527","article-title":"Metastatic malignant melanoma with complete loss of differentiation markers (Undifferentiated\/Dedifferentiated melanoma): analysis of 14 patients emphasizing phenotypic plasticity and the value of molecular testing as surrogate diagnostic marker","volume":"40","author":"Agaimy","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.canlet.2018.11.009_bib42","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1001\/jamadermatol.2015.1916","article-title":"Pembrolizumab cutaneous adverse events and their association with disease progression","volume":"151","author":"Sanlorenzo","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.canlet.2018.11.009_bib43","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jaad.2014.02.035","article-title":"Ipilimumab in patients with cancer and the management of dermatologic adverse events","volume":"71","author":"Lacouture","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.canlet.2018.11.009_bib44","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1046\/j.0022-202x.2001.01667.x","article-title":"Tyrosinase gene expression is regulated by p53","volume":"118","author":"Khlgatian","year":"2002","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.canlet.2018.11.009_bib45","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1600-0749.1996.tb00094.x","article-title":"Tumor suppressor p53 down-regulates tissue-specific expression of tyrosinase gene in human melanoma cell lines","volume":"9","author":"Kichina","year":"1996","journal-title":"Pigm. Cell Res."},{"key":"10.1016\/j.canlet.2018.11.009_bib46","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ccr.2013.08.018","article-title":"A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma","volume":"24","author":"Caramel","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2018.11.009_bib47","doi-asserted-by":"crossref","first-page":"12105","DOI":"10.1038\/ncomms12105","article-title":"A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis","volume":"7","author":"Gao","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2018.11.009_bib48","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1158\/0008-5472.CAN-04-3216","article-title":"Potent selection of antigen loss variants of B16 melanoma following inflammatory killing of melanocytes in vivo","volume":"65","author":"Sanchez-Perez","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2018.11.009_bib49","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nature11538","article-title":"Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation","volume":"490","author":"Landsberg","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2018.11.009_bib50","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2018.11.009_bib51","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1158\/1078-0432.CCR-05-2061","article-title":"Evaluation of prime\/boost regimens using recombinant poxvirus\/tyrosinase vaccines for the treatment of patients with metastatic melanoma","volume":"12","author":"Lindsey","year":"2006","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.canlet.2018.11.009_bib52","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/bjc.2014.476","article-title":"Beyond BRAF: where next for melanoma therapy?","volume":"112","author":"Fedorenko","year":"2015","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.canlet.2018.11.009_bib53","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ccr.2010.11.023","article-title":"Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R\/PI3K","volume":"18","author":"Villanueva","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2018.11.009_bib54","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cell.2017.10.027","article-title":"Cancer evolution during immunotherapy","volume":"171","author":"Andrews","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2018.11.009_bib55","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1755-8794-1-13","article-title":"The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis","volume":"1","author":"Riker","year":"2008","journal-title":"BMC Med. Genom."},{"key":"10.1016\/j.canlet.2018.11.009_bib56","doi-asserted-by":"crossref","first-page":"7234","DOI":"10.1158\/1078-0432.CCR-05-0683","article-title":"Novel genes associated with malignant melanoma but not benign melanocytic lesions","volume":"11","author":"Talantov","year":"2005","journal-title":"Clin. Canc. Res."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383518306736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383518306736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T01:44:18Z","timestamp":1694051058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383518306736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":56,"alternative-id":["S0304383518306736"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2018.11.009","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNp73-induced degradation of tyrosinase links depigmentation with EMT-driven melanoma progression","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2018.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}